The vertical farm network has pulled in $140m through a series D round led by SoftBank Vision Fnd and backed by commercial partner Driscoll’s.
Month: October 2020
Blackrock heralds Arrival with $118m investment
The electric bus and van developer has added cash from funds managed by BlackRock to money raised from Hyundai, Kia and UPS in January.
Spruce ups IPO to $104m
Novo-backed congenital adrenal hyperplasia drug developer Spruce Biosciences has added approximately $14m to close its initial public offering.
Vineti swells series C to $68m
The personalised medicine technology provider hiked its overall funding to $115m, with Cardinal Health, McKesson Ventures and Novartis all backing a series C extension.
Kasa Living cashes $50m
The Allegion-backed hospitality platform developer has secured $30m in series B financing to take its funding to $50m over the past year.
Nimbus notches up $60m
The protein drug developer has now secured more than $195m in total, its earlier backers including GlaxoSmithKline, Pfizer, Eli Lilly and Schrödinger.
Drone Fund lands on corporates for latest vehicle
Japan Asia Group, Kobashi Industries, NTT Docomo and SoftBank are among the LPs that have backed the drone-focused investment firm’s third vehicle, which has a $95m target.
BlackSwan floats into view with $28m
MS&AD Ventures co-led a series A round disclosed as the enterprise AI software provider exited stealth mode.
ImmuneOnco Biopharma imports $25m
Cancer drug developer ImmuneOnco has caught the attention of Eli Lilly’s Asia-focused vehicle and will put the series B proceeds toward clinical trials.
Matroid strikes $20m series B
Existing investor Intel Capital helped the computer vision software provider bring its funding to $33.5m to date.
Corporates help coat Actnano with $12m
Corporate venturing vehicles Henkel Tech Ventures, GC Ventures America and Ireon Ventures all took part in the coating material producer’s series A round.
GV finds the code for Nym Health
Alphabet subsidiary GV led a $16.5m series A round for the healthcare revenue management startup that followed a $6m round last year.
Rappta Therapeutics hits series A target
Novartis Venture Fund and Novo Seeds co-led a $10.4m round for oncology therapy developer Rappta on behalf of corporate parents Novartis and Novo.
Sella Venture Partners seals first close for fund
Sella Group’s debut fund of funds has secured Aviva, HDI Assicurazioni, Banca Sella, Banca Patrimoni Sella & C, Banco BPM and Fenera Holding for its $35.3m first close.